Lung Function and Asthma Clinical Control in N-ERD Patients, Three-Year Follow-Up in the Context of Real-World Evidence 👇 https://t.co/m89DY4ykBS #Asthma #Corticosteroids #RespiratoryDisease https://t.co/mfJ7GEcp0D
RT @NeumologiaPeru: 🔥🔥Lung Function and Asthma Clinical Control in N-ERD Patients, Three-Year Follow-Up in the Context of Real-World Eviden…
RT @NeumologiaPeru: 🔥🔥Lung Function and Asthma Clinical Control in N-ERD Patients, Three-Year Follow-Up in the Context of Real-World Eviden…
RT @RFalfanV: In this paper, @gandhifer identified that just one-third of Nonsteroidal anti-inflammatory drug-exacerbated respiratory disea…
RT @RFalfanV: In this paper, @gandhifer identified that just one-third of Nonsteroidal anti-inflammatory drug-exacerbated respiratory disea…
RT @RFalfanV: In this paper, @gandhifer identified that just one-third of Nonsteroidal anti-inflammatory drug-exacerbated respiratory disea…
🔥🔥Lung Function and Asthma Clinical Control in N-ERD Patients, Three-Year Follow-Up in the Context of Real-World Evidence 🫁🏅🔝🎯 https://t.co/aY10oGgs6S @SallyWenzel @Paulwnoblemd @wytskefokkens @DarioAntolin @gemasma @pulmonology101 @DocdelOlmo @drgochis @a
RT @RFalfanV: In this paper, @gandhifer identified that just one-third of Nonsteroidal anti-inflammatory drug-exacerbated respiratory disea…
In this paper, @gandhifer identified that just one-third of Nonsteroidal anti-inflammatory drug-exacerbated respiratory disease (N-ERD) patients can gradually achieve adequate #LungFunction & good #asthma control with a high #ICS dosage. | JAA @DovePr